Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,106 | -108,025 | -98,144 | -71,015 | -25,923 |
| Depreciation Amortization | 16,413 | 69,821 | 53,043 | 36,225 | 17,728 |
| Accounts receivable | -8,182 | -6,178 | -1,971 | 397 | -668 |
| Other Working Capital | -12,198 | -32,095 | -16,455 | -16,229 | -7,285 |
| Other Operating Activity | 12,936 | 81,707 | 67,414 | 45,625 | -9,179 |
| Operating Cash Flow | $-8,137 | $5,230 | $3,887 | $-4,997 | $-25,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 20,060 | 20,060 | 11,060 | 8,060 |
| PPE Investments | -5,000 | -24,942 | -19,137 | -10,823 | -4,500 |
| Net Acquisitions | N/A | -6,454 | -6,454 | -5,991 | N/A |
| Purchase Of Investment | N/A | -1,000 | -500 | N/A | N/A |
| Investing Cash Flow | $-5,000 | $-12,336 | $-6,031 | $-5,754 | $3,560 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -201,250 | -201,250 | -201,250 | N/A |
| Common Stock Issued | -338 | 962 | 531 | -234 | 949 |
| Financing Cash Flow | $-338 | $-200,288 | $-200,719 | $-201,484 | $949 |
| Beginning Cash Position | 159,618 | 367,012 | 367,012 | 367,012 | 367,012 |
| End Cash Position | 146,143 | 159,618 | 164,117 | 154,723 | 346,194 |
| Net Cash Flow | $-13,475 | $-207,394 | $-202,895 | $-212,289 | $-20,818 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,137 | 5,230 | 3,887 | -4,997 | -25,327 |
| Capital Expenditure | -5,000 | -27,008 | -19,137 | -10,823 | -4,500 |
| Free Cash Flow | -13,137 | -21,778 | -15,250 | -15,820 | -29,827 |